guaifenesin has been researched along with Bronchopulmonary Dysplasia in 1 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmidt, HJ | 1 |
| Bhandari, V | 1 |
| Bhandari, A | 1 |
| Davies, J | 1 |
| Marshall, BC | 1 |
| Praud, JP | 1 |
| Zar, HJ | 1 |
| Rubin, BK | 1 |
1 review available for guaifenesin and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
The future in paediatric respirology.
Topics: Adult; Asthma; Bronchopulmonary Dysplasia; Child; Chronic Disease; Cystic Fibrosis; Humans; Infant, | 2010 |